Preparation and characterization of rilpivirine solid dispersions with the application of enhanced solubility and dissolution rate

Amidon, 1995, A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm Res, 12, 413, 10.1023/A:1016212804288 Anita, 2012, Bioequivalence of the emtricitabine/rilpivirine/tenofovir disoproxil fumarate single tablet regimen, J Bioequiv Availab, 4, 100 Baert, 2009, Development of a long-acting injectable formulation with nanoparticles of rilpivirine (tmc278) for hiv treatment, Eur J Pharm Biopharm, 72, 502, 10.1016/j.ejpb.2009.03.006 Chiou, 1971, Pharmaceutical applications of solid dispersion systems, J Pharm Sci, 60, 1281, 10.1002/jps.2600600902 Goebel, 2006, Short-term antiviral activity of tmc278-a novel nnrti-in treatment-naive hiv-1-infected subjects, Aids, 20, 1721, 10.1097/01.aids.0000242818.65215.bd Hancock, 1997, Characteristics and significance of the amorphous state in pharmaceutical systems, J Pharm Sci, 86, 1, 10.1021/js9601896 Karavas, 2007, Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug–polymer interactions, Eur J Pharm Biopharm, 66, 334, 10.1016/j.ejpb.2006.11.020 Jahan, 2011, Enhancement of dissolution profile for oral delivery of fexofenadine hydrochloride by solid dispersion (solvent evaporation) technique, Am J Sci Ind Res, 2, 112 Leuner, 2000, Improving drug solubility for oral delivery using solid dispersions, Eur J Pharm Biopharm, 50, 47, 10.1016/S0939-6411(00)00076-X Patel, 2006, Fast dissolving valdecoxib tablets containing solid dispersion of valdecoxib, Indian J Pharm Sci, 68, 222, 10.4103/0250-474X.25719 Porter, 2008, Enhancing intestinal drug solubilisation using lipid-based delivery systems, Adv Drug Deliv Rev, 60, 673, 10.1016/j.addr.2007.10.014 Rautio, 2008, Prodrugs: design and clinical applications, Nat Rev Drug Discov, 7, 255, 10.1038/nrd2468 Serajuddin, 1999, Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs, J Pharm Sci, 88, 1058, 10.1021/js980403l Sethia, 2004, Solid dispersion of carbamazepine in pvp k30 by conventional solvent evaporation and supercritical methods, Int J Pharm, 272, 1, 10.1016/j.ijpharm.2003.11.025 Sharma, 2010, Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-hiv drugs, Adv Drug Deliv Rev, 62, 491, 10.1016/j.addr.2009.11.019 Stegemann, 2007, When poor solubility becomes an issue: from early stage to proof of concept, Eur J Pharm Sci, 31, 249, 10.1016/j.ejps.2007.05.110 Stellbrink, 2007, Antiviral drugs in the treatment of aids: what is in the pipeline?, Eur J Med Res, 12, 483 Vasconcelos, 2007, Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs, Drug Discov Today, 12, 1068, 10.1016/j.drudis.2007.09.005 Veiga, 1996, Inclusion complexation of tolbutamide with β-cyclodextrin and hydroxypropyl-β-cyclodextrin, Int J Pharm, 129, 63, 10.1016/0378-5173(95)04243-1 Xie, 2009, Preparation and in vitro evaluation of solid dispersions of total flavones of hippophae rhamnoides l, AAPS Pharm Sci Tech, 10, 631, 10.1208/s12249-009-9246-x